Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Winzeler

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenDavid Plouffe, Achim Brinker, Case McNamara, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
AI-Accelerated Structure Elucidation of Boavistamides A-C, Cyclic Depsipeptides from a Marine Filamentous Cyanobacterium Collected in Cabo VerdeMarine Cuau, Nicole E Avalon, Byeol Ryu, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human KinasesLushun Wang, Monica J Bohmer, Jinhua Wang, et al.
ACS Chemical Biology|December 16, 2016
Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive YeastSabine Ottilie, Gregory M Goldgof, Claudia Magalhaes Calvet, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria ParasiteKatherine M Ellis, Leonardo Lucantoni, Marina Chavchich, et al.
Scientific Reports|June 14, 2016
Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitorGregory M Goldgof, Jacob D Durrant, Sabine Ottilie, et al.
Cell|March 27, 2018
Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium InfectionShang Ma, Stuart Cahalan, Gregory LaMonte, et al.
Diabetes Care|January 6, 2025
Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 DiabetesArjana Begzati, Karla P Godinez-Macias, Tao Long, et al.
Nature Communications|September 20, 2018
A high throughput screen for next-generation leads targeting malaria parasite transmissionMichael J Delves, Celia Miguel-Blanco, Holly Matthews, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2008
In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screenDavid Plouffe, Achim Brinker, Case McNamara, et al.
Biorxiv : the Preprint Server for Biology|June 29, 2026
AI-Accelerated Structure Elucidation of Boavistamides A-C, Cyclic Depsipeptides from a Marine Filamentous Cyanobacterium Collected in Cabo VerdeMarine Cuau, Nicole E Avalon, Byeol Ryu, et al.
Journal of Medicinal Chemistry|January 12, 2024
Discovery of Potent Antimalarial Type II Kinase Inhibitors with Selectivity over Human KinasesLushun Wang, Monica J Bohmer, Jinhua Wang, et al.
ACS Chemical Biology|December 16, 2016
Rapid Chagas Disease Drug Target Discovery Using Directed Evolution in Drug-Sensitive YeastSabine Ottilie, Gregory M Goldgof, Claudia Magalhaes Calvet, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria ParasiteKatherine M Ellis, Leonardo Lucantoni, Marina Chavchich, et al.
Scientific Reports|June 14, 2016
Comparative chemical genomics reveal that the spiroindolone antimalarial KAE609 (Cipargamin) is a P-type ATPase inhibitorGregory M Goldgof, Jacob D Durrant, Sabine Ottilie, et al.
Cell|March 27, 2018
Common PIEZO1 Allele in African Populations Causes RBC Dehydration and Attenuates Plasmodium InfectionShang Ma, Stuart Cahalan, Gregory LaMonte, et al.
Diabetes Care|January 6, 2025
Plasma Lipid Metabolites, Clinical Glycemic Predictors, and Incident Type 2 DiabetesArjana Begzati, Karla P Godinez-Macias, Tao Long, et al.
Nature Communications|September 20, 2018
A high throughput screen for next-generation leads targeting malaria parasite transmissionMichael J Delves, Celia Miguel-Blanco, Holly Matthews, et al.
Journal of Medicinal Chemistry|October 31, 2018
Target Validation and Identification of Novel Boronate Inhibitors of the Plasmodium falciparum ProteasomeStanley C Xie, David L Gillett, Natalie J Spillman, et al.
Pageof 23